Coeptis Therapeutics Holdings
Tracked across 2 events · 13 articles · First seen Apr 17, 2025 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Coeptis Therapeutics Holdings held its Annual General Meeting where shareholders approved most proposals, re-elected and elected new board members, and approved financial statements. However, a proposal to increase conditional share capital was not approved, which could limit future fundraising flexibility.
Jun 25, 2026 · 7 articles
Business
Impact: Coeptis Therapeutics Holdings is advancing its strategy to secure reimbursement for at-home neurorehabilitation solutions in Europe by enrolling patients in the SwissNeuroRehab and REACT-AVC studies. This move is expected to expand its market reach and revenue streams.
Jul 01, 2026 · 6 articles
90
Coeptis Therapeutics Holdings published invitationMindMaze Therapeutics AGM Results
90
Coeptis Therapeutics Holdings enrolled first patients SwissNeuroRehabMindMaze Therapeutics...
70
Coeptis Therapeutics Holdings re-elected directorsMindMaze Therapeutics AGM Results
60
Coeptis Therapeutics Holdings sought approvalMindMaze Therapeutics AGM Results
Bain Capital
investee
↔
Coeptis Therapeutics Holdings
Coeptis Therapeutics Holdings is an investee of Bain Capital, which orchestrated
AbbVie
target
↔
Coeptis Therapeutics Holdings
Cerevel Therapeutics Holdings agreed to be acquired by pharmaceutical giant AbbV
Bain Capital
investor
↔
Coeptis Therapeutics Holdings
Bain Capital holds an equity position in Coeptis Therapeutics Holdings, which it
ERGEN INTELLIGENCE
Track Coeptis Therapeutics Holdings live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard